BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Diagnosis
23 results:

  • 1. Presentation and outcomes of paediatric craniopharyngioma in the west of Scotland: a 25 year experience.
    Kuah XYC; Lucas-Herald AK; McCarrison S; Boyle R; Adey C; Amato-Watkins A; Bhattathiri P; Campbell E; Cowie F; Dorris L; Fulton B; Mcintosh D; Murphy D; Ronghe M; O'Kane R; Todd L; Sangra M; Sastry J; Millar E; Hassan S; Shaikh MG
    J Neurooncol; 2024 Jan; 166(1):51-57. PubMed ID: 38224403
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
    Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
    Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
    Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
    Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exosomal RNAs in the development and treatment of pituitary adenomas.
    Chang M; Jiang S; Guo X; Gao J; Liu P; Bao X; Feng M; Wang R
    Front Endocrinol (Lausanne); 2023; 14():1142494. PubMed ID: 36875488
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MYB/MYBL1::QKI fusion-positive diffuse glioma.
    Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
    J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered.
    Zhao JP; Liu XJ; Lin HZ; Cui CX; Yue YJ; Gao S; Xu HZ
    BMC Neurol; 2022 Dec; 22(1):498. PubMed ID: 36550486
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.
    Parmar A; Ghosh S; Sahgal A; Lalani AA; Hansen AR; Reaume MN; Wood L; Basappa NS; Heng DYC; Graham J; Kollmannsberger C; Soulières D; Breau RH; Tanguay S; Kapoor A; Pouliot F; Bjarnason GA
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1763. PubMed ID: 36517084
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.
    Michel A; Dinger TF; Santos AN; Pierscianek D; Darkwah Oppong M; Ahmadipour Y; Dammann P; Wrede KH; Hense J; Pöttgen C; Iannaccone A; Kimmig R; Sure U; Jabbarli R
    J Neurooncol; 2022 Aug; 159(1):53-63. PubMed ID: 35672530
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetic Markers as Predictors for Response to Treatment and Possible Therapeutic Targets in Medulloblastoma.
    Pérez-Pineda PL; Ortiz-Butrón R; Pérez-De Marcos JC; Hernández-Regino LM; Zapata-Tarrés MM; Torres-Espíndola LM
    CNS Neurol Disord Drug Targets; 2023; 22(5):634-642. PubMed ID: 35579144
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations.
    Lazow MA; Leach JL; Trout AT; Breneman JC; Fouladi M; Fuller C
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e597-e604. PubMed ID: 33974582
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dissociation of Pubertal Development Abnormality and Gonadal Dysfunction in Childhood cancer Survivors.
    Yu B; Fritz R; Vega M; Merino M
    J Adolesc Young Adult Oncol; 2020 Aug; 9(4):490-495. PubMed ID: 32186962
    [No Abstract]    [Full Text] [Related]  

  • 13. CDK4, cdk6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component.
    Xu G; Li JY
    J Neurooncol; 2018 Feb; 136(3):445-452. PubMed ID: 29150788
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence.
    Baysan M; Woolard K; Cam MC; Zhang W; Song H; Kotliarova S; Balamatsias D; Linkous A; Ahn S; Walling J; Belova GI; Fine HA
    Int J Cancer; 2017 Nov; 141(10):2002-2013. PubMed ID: 28710771
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells.
    Jiang BY; Li YS; Guo WB; Zhang XC; Chen ZH; Su J; Zhong WZ; Yang XN; Yang JJ; Shao Y; Huang B; Liu YH; Zhou Q; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Wu SY; Gao CY; Zhang X; Wu YL
    Clin Cancer Res; 2017 Sep; 23(18):5480-5488. PubMed ID: 28606923
    [No Abstract]    [Full Text] [Related]  

  • 16. Congenital Glioblastoma with Distinct Clinical and Molecular Characteristics: Case Reports and a Literature Review.
    Kameda M; Otani Y; Ichikawa T; Shimada A; Ichimura K; Date I
    World Neurosurg; 2017 May; 101():817.e5-817.e14. PubMed ID: 28214639
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas.
    Kim MS; Kim KH; Lee EH; Lee YM; Lee SH; Kim HD; Kim YZ
    J Neurosurg; 2014 Nov; 121(5):1189-200. PubMed ID: 25148008
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Neurologic complications in renal transplantation.
    Potluri K; Holt D; Hou S
    Handb Clin Neurol; 2014; 121():1245-55. PubMed ID: 24365416
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The natural history of thyroid function abnormalities after treatment for childhood cancer.
    Madanat LM; Lähteenmäki PM; Alin J; Salmi TT
    Eur J Cancer; 2007 May; 43(7):1161-70. PubMed ID: 17391953
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study.
    Vestergaard P; Jørgensen JO; Hagen C; Hoeck HC; Laurberg P; Rejnmark L; Brixen K; Weeke J; Andersen M; Conceicao FL; Nielsen TL; Mosekilde L
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):159-67. PubMed ID: 11874406
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.